Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between ANG Lifesciences IPO and Geekay Wires IPO.
ANG Lifesciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Geekay Wires IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| ANG Lifesciences IPO | Geekay Wires IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Guiness Corporate Advisors Pvt Ltd | Aryaman Financial Services Limited |
| Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Geekay Wires IPO is up to ₹11.00 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Geekay Wires IPO is ₹33.00 per share.
| ANG Lifesciences IPO | Geekay Wires IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹80.00 per share | ₹33.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 15,00,800 shares | 33,32,000 shares |
| Issue Size Total (Amount) | up to ₹12.01 Cr | up to ₹11.00 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Geekay Wires IPO opens on Aug 09, 2017. The closing date of ANG Lifesciences IPO and Geekay Wires IPO is Aug 31, 2017, and Aug 14, 2017, respectively.
| ANG Lifesciences IPO | Geekay Wires IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Aug 09, 2017 |
| Issue Close | Aug 31, 2017 | Aug 14, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Geekay Wires IPO P/E ratio of .
| ANG Lifesciences IPO | Geekay Wires IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Geekay Wires IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Geekay Wires IPO.
| ANG Lifesciences IPO | Geekay Wires IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 0 shares | 0 shares |
| NII | 7,12,000 shares | 16,66,000 shares |
| RII | 7,12,000 shares | 16,66,000 shares |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares | 33,32,000 shares |
ANG Lifesciences IPO subscribed in total, whereas Geekay Wires IPO subscribed .
| ANG Lifesciences IPO | Geekay Wires IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
